financetom
Business
financetom
/
Business
/
Sebi amends rules; intermediaries requires prior approval for change in control
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sebi amends rules; intermediaries requires prior approval for change in control
Jan 20, 2023 2:16 PM

Capital markets regulator Sebi has amended rules which require vault managers and custodians to seek the watchdog’s prior approval in case of change in control. The changes have been made to streamline the process of providing approval to the proposed change in control of the entities.

Share Market Live

NSE

In a notification, the Securities and Exchange Board of India (Sebi) said that the vault managers and Custodians will have to obtain prior approval of the Board in case of change in control in such a manner as specified by the regulator.

To give this effect, Sebi has amended rules governing custodian and vault managers and the new rule has become effective from January 17.

Also read: SEBI bans person from securities market in unauthorised investment advisory services case

Vault manager is regulated as a Sebi intermediary for providing vaulting services meant for gold deposited to create electronic gold receipts (EGRs). The obligations of the vault manager include accepting deposits, storage and safekeeping of gold, creation as well as withdrawal of EGR, grievance redressal and periodic reconciliation of physical gold with the records of depository.

Custodian means any person who carries on the business of providing custodial services.

In November 2022, the markets regulator had put in place a revised framework for seeking its prior approval for changes in control of stock brokers, depository participants and other market intermediaries.

Also read: Equitas Holdings sets Record Date for share exchange with Equitas Small Finance Bank in amalgamation scheme

The framework was applicable for stock broker/clearing member, depository participant, investment adviser, research analyst or research entity, registrar to an issue and share transfer agent and KYC (Know Your Client) Registration Agencies (KRAs).

Under this, an intermediary is required to apply online for Sebi’s prior approval and along with the application, the entity concerned has to submit various details, including the current and proposed shareholding pattern of the applicant.

The prior approval granted by Sebi is valid for a period of six months from the date of such approval within which the applicant needs to file application for fresh registration pursuant to change in control.

Also read: SEBI probes investments between Nippon Mutual Fund, Yes Bank: Sources

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Oracle Unusual Options Activity
Oracle Unusual Options Activity
Jul 30, 2025
Whales with a lot of money to spend have taken a noticeably bullish stance on Oracle. Looking at options history for Oracle we detected 10 trades. If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish expectations and 30% with bearish. From the overall spotted trades, 2 are...
AbbVie Says Phase 3 Trial of Upadacitinib in Alopecia Areata Meets Endpoints
AbbVie Says Phase 3 Trial of Upadacitinib in Alopecia Areata Meets Endpoints
Jul 30, 2025
10:01 AM EDT, 07/30/2025 (MT Newswires) -- AbbVie ( ABBV ) said Wednesday that one of two phase 3 pivotal studies of upadacitinib in adult and adolescent patients with severe alopecia areata met its primary endpoint of more scalp hair coverage and key secondary endpoints of improvements in eyebrows and eyelashes. The company said 44.6% and 54.3% of the patients...
Teva Pharm CEO says drugs sector facing 'big ambiguity' over US tariffs
Teva Pharm CEO says drugs sector facing 'big ambiguity' over US tariffs
Jul 30, 2025
JERUSALEM, July 30 (Reuters) - The CEO of Israel's Teva Pharmaceutical Industries said on Wednesday there was big ambiguity and so many unanswered questions in the drugs sector regarding potential U.S. tariffs, but the company was positioned for minimal impact. Richard Francis said 70% of Teva's generics business was outside of the United States while most of its branded drugs...
Copyright 2023-2025 - www.financetom.com All Rights Reserved